The WHO Regional Office for Africa, in a statement issued
from its headquarters in Brazzaville, Congo on Thursday stated the continent
was planning for a rapid vaccine rollout.
The statement said Dr. Matshidiso Moeti, WHO Regional
Director for Africa had on Wednesday briefed Health Ministers on the region’s
overall state of readiness for Africa’s largest-ever immunization drive.
She also briefed them on planned vaccine delivery dates and
next steps, including documentation required by COVAX related to regulatory
readiness, indemnity and liability agreements so vaccine manufacturers could
schedule shipment dates.
According to the UN health agency, rapid vaccine rollout is
expected in the wake of the WHO listing of two versions of the
AstraZeneca-Oxford COVID-19 vaccine for emergency use.
“In a significant step forward for the African region,
national deployment and vaccination plans for COVID-19 vaccines from 35
low-income African countries eligible for free vaccines from the COVAX Facility
have been accepted by an independent regional review committee.
“The plans are required for countries to receive vaccines
from COVAX, the global initiative to ensure fair access to COVID-19 vaccines
led by WHO, Gavi, the Vaccine Alliance, and The Coalition for Epidemic
Preparedness Innovations (CEPI).
“While the regional committee of over 100 experts from six
leading global public health bodies certified the deployment plans, it called
for more work on setting up systems.
“It called for more work on setting up systems to manage the
logistics and supply chain for vaccines, reaching refugees, migrants and
internally displaced people and financing national vaccination campaigns,” said
the statement.
The statement quoted Moeti, as saying, “Africa is revving up
to rollout COVID-19 vaccines.
“These thorough vaccine preparation plans will help ensure
African countries can hit the ground running in quickly immunising the most
vulnerable people.
“Meticulous planning is key to ensuring vaccines reach all
priority groups, wherever they are, in every single African country.”
The statement also quoted Thabani Maphosa, Managing
Director, Country Programmes, GAVI, as saying, “COVAX is open for business.
“Thanks to secured avenues of supply through manufacturer
deals and dose-sharing, clarity on global and regional supply forecasts,
additional much-needed funding, and countries’ hard work to ensure readiness.
“The world now has its clearest pathway yet to ending the
acute stage of this pandemic, globally.”
According to WHO, the move to roll out COVID-19 vaccines comes
as new evidence shows new variants of the virus are spreading across the
continent.
It stated that in all the African countries that had
detected the new variants, the pandemic spread faster in the second wave than
in the first one.
Variant 501Y.V2 [also known as B1.351] first identified in
South Africa is predominant in South Africa and Zambia and has been detected in
a total of nine African nations including Botswana, Comoros, Ghana, Kenya,
Mozambique, South Africa, Tanzania, Zambia and Zimbabwe.
The VOC202012/01variant [also known as B1.1.7] first
detected in the United Kingdom has been found in six African countries, Gambia,
Ghana, Morocco, Nigeria, Senegal, South Africa.
In addition, it stated that countries were strongly urged to
use the AstraZeneca vaccine even if the SARS-CoV-2 new variants are present.
“A small South African study has found the vaccine was not
very effective against mild and moderate cases infected with the 501Y.V2
variant.
“After a review of all available data the WHO Strategic
Advisory Group of Experts concluded that ongoing research suggests that the
Astra Zeneca vaccine is likely to protect people against severe COVID-19
“However, this remains to be demonstrated in clinical trials
and post-implementation evaluation,” WHO stated.
The statement further quoted Moeti, as saying, “our priority
must be to protect the most vulnerable from severe illness and death. Along
with rolling out safe and proven vaccines, we must also work towards a diverse
vaccine portfolio.
“At the same time, manufacturers must be prepared to adjust
to mutations of the virus, including potentially providing booster shots and
adapted vaccines.”
WHO is helping countries ramp-up sequencing capacities to
detect new variants. Since December 2020, there has been a 50 per cent increase
in sequences produced by over 30 African countries.
0 comments:
Post a Comment